Literature DB >> 11919419

Histopathological and immunohistochemical aspects of mastocytosis.

Hans-Peter Horny1, Peter Valent.   

Abstract

The diagnosis of mastocytosis is based on histological evidence of a focal increase in tissue mast cells. Immunohistochemical staining with antitryptase antibodies is strongly recommended in all cases of suspected mastocytosis because mast cell infiltrates may be small and scanty. Mastocytosis may be difficult to distinguish from other hematological malignancies, in which an increase in mast cells is frequently seen. The expression of the T cell-associated antigen CD2 has been shown to be exclusively found on neoplastic mast cells in mastocytosis. The demonstration of expression of vascular endothelial growth factor by mast cells is consistent with the finding of angiogenesis which is commonly seen in tissue infiltrates of mastocytosis. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11919419     DOI: 10.1159/000048180

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  8 in total

1.  The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.

Authors:  H-P Horny; K Sotlar; F Stellmacher; M Krokowski; H Agis; L B Schwartz; P Valent
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

2.  Severe chronic diarrhea and maculopapular rash: a case report.

Authors:  Alessandra Elvevi; Federica Grifoni; Federica Branchi; Umberto Gianelli; Dario Conte
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

Review 3.  Mastocytosis.

Authors:  Knut Brockow; Dean D Metcalfe
Journal:  Chem Immunol Allergy       Date:  2010-06-01

4.  Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis.

Authors:  Jeffrey W Craig; Robert P Hasserjian; Annette S Kim; Jon C Aster; Geraldine S Pinkus; Jason L Hornick; David P Steensma; R Coleman Lindsley; Daniel J DeAngelo; Elizabeth A Morgan
Journal:  Mod Pathol       Date:  2020-01-02       Impact factor: 7.842

5.  Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.

Authors:  Daniela Silva Moura; Serge Sultan; Sophie Georgin-Lavialle; Nathalie Pillet; François Montestruc; Paul Gineste; Stéphane Barete; Gandhi Damaj; Alain Moussy; Olivier Lortholary; Olivier Hermine
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

6.  VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model.

Authors:  R Patruno; N Arpaia; C D Gadaleta; L Passantino; N Zizzo; A Misino; N M Lucarelli; A Catino; P Valerio; D Ribatti; G Ranieri
Journal:  J Cell Mol Med       Date:  2008-04-18       Impact factor: 5.310

7.  Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management.

Authors:  Francesca Crupi; Benedetta Sordi; Fiorenza Vanderwert; Francesca Gesullo; Andrea Amorosi; Francesco Mannelli; Raffaella Santi
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

Review 8.  Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms.

Authors:  Gregor Hoermann; Georg Greiner; Peter Valent
Journal:  Mediators Inflamm       Date:  2015-10-12       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.